Skip to content

Drug interactions

Hydralazine + Pexidartinib

Severity: Moderate

Hydralazine and Pexidartinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Pexidartinib carries a boxed warning for serious liver injury, and hydralazine has been associated with rare cases of hepatotoxicity. The combination could add to hepatic risk, though the contribution of hydralazine is small.

What this interaction means in plain words

Hydralazine and Pexidartinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Hydralazine belongs to Cardiovascular; Pexidartinib belongs to Oncology.

Evidence level: Low

Why it happens

Potential additive hepatotoxicity.

What to do

Monitor liver enzymes and bilirubin regularly during combined therapy. Stop the suspected agent if liver injury develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Hydralazine and Pexidartinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Hydralazine with Pexidartinib?

MediHelp rates the interaction as moderate. Hydralazine and Pexidartinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Pexidartinib carries a boxed warning for serious liver injury, and hydralazine has been associated with rare cases of hepatotoxicity. The combination could add to hepatic risk, though the contribution of hydralazine is small.

How serious is the interaction between Hydralazine and Pexidartinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor liver enzymes and bilirubin regularly during combined therapy. Stop the suspected agent if liver injury develops.

What other medicines interact with Hydralazine?

MediHelp also lists interactions of Hydralazine with, for example, Amifostine, Aceclofenac, Acemetacin. The full list is on the Hydralazine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in